Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Discovery of novel cathepsin C inhibitor with anti-inflammatory activity in vivo

June 14, 2022

For mutations, "synonymous" is not a synonym for silent, study finds

June 9, 2022

Long in the making changes lead to tipping point in blood stem cells

June 3, 2022

Study shows disease-linked DNA variants are active at different stages of T-cell activation

May 30, 2022

CNPY4 knockout embryos exhibit hedgehog signaling hyperactivation-driven defects

May 26, 2022

Evotec International discovers integrated stress response pathway modulators

May 18, 2022

Multiple aging hallmarks show up as epigenetic changes

May 17, 2022

Across body parts, "parts list" gives insights into the lives of a cell

May 13, 2022

Sichuan Haisco Pharmaceutical divulges new JAK inhibitors

May 12, 2022

CD38 inhibitors discovered at Napa Therapeutics, Buck Institute

May 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...